Maturation of pluripotent stem cell-derived cardiomyocytes: limitations and challenges from metabolic aspects
Abstract Acute coronary syndromes, such as myocardial infarction (MI), lack effective therapies beyond heart transplantation, which is often hindered by donor scarcity and postoperative complications. Human induced pluripotent stem cells (hiPSCs) offer the possibility of myocardial regeneration by d...
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
BMC
2024-10-01
|
| シリーズ: | Stem Cell Research & Therapy |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s13287-024-03961-4 |